Rachel Smith is a clinical operations professional with over 10 years of experience in clinical research, particularly in rare disease, gene, and cell therapies. She completed her Bachelor's degree in Biochemistry with First Class Honours at the University of Warwick. Smith has worked with several organizations throughout her career, including Veristat, The CLINICAL TRIAL Company Ltd, Scope International AG, and GlaxoSmithKline. Her global experience ranges from strategic planning to Phase I-III to post-licensing data collection trials in adult and pediatric populations. Smith specializes in rescue studies, unique set-ups, and products with non-classical routes to market.

As a Project Director at Veristat, Rachel Smith brings a wealth of expertise to the table. With her extensive experience and specialty knowledge in rare disease, gene, and cell therapies, Smith oversees clinical operations from strategic planning through to post-licensing data collection trials. Her expertise in rescue studies, unique set-ups, and products with non-classical routes to market makes her particularly well-suited for her role.